SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Novartis suspends eight CAR-T trials after three patient deaths

Novartis AG has reportedly suspended eight clinical trials of an experimental CAR-T treatment after three patients died, according to The Wall Street Journal. The trials were stopped after the company learned of the deaths in late August.

NOT

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories